Pharmafile Logo
Pharmafocus logo
Advanced Search
roche__tree

Roche’s Ocrevus cleared for NHS use in relapsing-remitting MS

June 22, 2018
Medical Communications, Sales and Marketing MS, NICE, UK, multiple sclerosis, pharma

Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended …

News
shutterstock_141299494

Elderly cancer cases to increase 80% by 2035, says CRUK

June 21, 2018
Medical Communications, Research and Development CRUK, Cancer, Cancer Research UK, NHS, UK, pharma

A new report from Cancer Research UK has indicated that the number of UK  citizens over the age of 75 …

News
920x920

Purdue culls 350 positions, eradicates sales force

June 21, 2018
Medical Communications, Sales and Marketing Purdue Pharma, opioid crisis, opioids, pharma

Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue …

News
shutterstock_38078521

Anika’s osteoarthritis pain drug falls short at Phase 3

June 21, 2018
Research and Development Anika Therapeutics, Cingal, osteoarthritis, pharma

Anika Therapeutics has become the latest in a recent string of firms to suffer a failure in a late-stage trial, …

News

Novo’s oral semaglutide beats Victoza and Januvia in diabetes

June 21, 2018
Research and Development Januvia, MSD, Novo Nordisk, Victoza, pharma, semaglutide

Novo Nordisk has released new data for its oral semaglutide diabetes therapy from two trials, showing that the GLP-1 analogue …

News
shutterstock_138095450

Aquinnah Pharmaceuticals receives $3.4 million grant to advance ALS therapies

June 21, 2018
Research and Development, Sales and Marketing Aquinnah Pharmaceuticals, als, amyotrophic lateral sclerosis, pharma

Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders …

News
nhs_sign

NHS could save £7 billion via new diagnostic techniques

June 20, 2018
Medical Communications, Research and Development NHS, pharma

Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) has revealed that the NHS could save …

News
shutterstock_159488225

Sarepta shares surge after gene therapy leads to microdystrophin expression in DMD patients

June 20, 2018
Research and Development Duchenne Muscular Dystrophy, pharma, sarepta

This week, shares in Sarepta Therapeutics rocketed by 80% after the company released preliminary data from a Phase 1/2a trial …

News
novo_nordisk_flag

Kallyope and Novo Nordisk announce obesity and diabetes collaboration

June 20, 2018
Research and Development Kallyope, Novo Nordisk, diabetes, obesity, pharma

Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the …

News
shutterstock

“Extremely promising” blood test for autism impresses with 88% accuracy

June 20, 2018
Research and Development autism, pharma

A blood test designed to support the clinical determination of whether a child is on the autistic spectrum has been …

News
Pharma on Facebook

Facebook unveils new feature to battle opioid crisis

June 20, 2018
Medical Communications, Research and Development, Sales and Marketing FDA, Facebook, US, opioid crisis, opioids, pharma

Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing …

News

FDA places hold on Ziopharm CAR-T trial

June 19, 2018
Manufacturing and Production, Research and Development CAR-T, FDA, pharma, ziopharm

CAR-T is emerging as one of the most potentially exciting therapies in the industry, particularly as a beacon for the …

News
ptc

PTC Therapeutics’ results in SMA has Biogen nervous

June 19, 2018
Manufacturing and Production, Research and Development Biogen, PTC Therapeutics, biotech, drugs, pharma, pharmaceutical

Biogen currently has the only product on the market approved to treat spinal muscular atrophy (SMA), in Spinraza, and that …

News
valeant_web

FDA rejects Valeant plaque psoriasis lotion over pharmacokinetic concerns

June 19, 2018
Manufacturing and Production, Sales and Marketing FDA, Valeant, pharma, psoriasis

Beleaguered pharma firm Valeant has come up against another bump in the road as its plaque psoriasis lotion Duobrii (halobetasol …

News
roche__tree

Roche buys out rest of Foundation Medicine for $2.4bn

June 19, 2018
Manufacturing and Production, Sales and Marketing Foundation Medicine, Roche, biotech, drugs, pharma, pharmaceutical

Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership …

News
8659041633_851995ca6c_z

Theranos founder charged with fraud

June 18, 2018
Manufacturing and Production, Medical Communications Theranos, biotech, drugs, pharma, pharmaceutical

Going from the youngest female self-made billionaire in the world to being charged with engaging in schemes to defraud investors …

News
facilities_lg06

Dr Reddy’s just-approved opioid dependence generic blocked over US patent dispute

June 18, 2018
Sales and Marketing Dr Reddy's, FDA, Mylan, US, opioid crisis, opioid dependence, opioids, suboxone

Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) …

News
data

Maintaining control: The rising challenges of clinical data management

June 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

From breach scandals to GDPR, data is becoming a more prominent part of our everyday lives. This holds great potential …

Feature
vaccination-2722937_960_720_1

HPV vaccine slashes rate of infection by 86% in UK

June 18, 2018
Medical Communications, Sales and Marketing HPV, biotech, drugs, pharma, pharmaceutical, vaccination

Since the introduction of the vaccination against the Human Papilloma Virus in 2008, there has been an 86% drop in …

News
teva_copy

Teva axes Phase 3 trial into chronic cluster headache

June 18, 2018
Research and Development, Sales and Marketing Teva, fremanezumab, headache, pharma

With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026